Sequential Profiling of Anti-SARS CoV-2 IgG Antibody in Post COVID-19 Patients
Autor: | Ajaikumar Sukumaran, Jofy K Paul, Thushara Thomas, R. Arun Krishnan, Deepa K Vijayan, Rhema Elizabeth Thomas, Damodaran Vasudevan, Riji Thomas |
---|---|
Rok vydání: | 2021 |
Předmět: |
Coronavirus disease 2019 (COVID-19)
biology business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) fungi Clinical Biochemistry COVID-19 In vitro Titer Immune system Immunology biology.protein Medicine ELISA HRP Original Research Article Anti-RBD SARS CoV-2 IgG Antibody Seroconversion business Receptor binding domain Binding domain |
Zdroj: | Indian Journal of Clinical Biochemistry |
ISSN: | 0974-0422 0970-1915 |
DOI: | 10.1007/s12291-021-00998-7 |
Popis: | Upon SARS CoV-2 infection, humoral immune system triggers production of anti-SARS CoV-2 IgM and IgG antibodies. Currently, antibodies against SARS CoV-2 spike protein receptor binding domain play a central role in disease protection, making them potential target for in vitro diagnostics applications. This study determines the expression level and sustainability of anti-receptor binding domain (RBD) SARS CoV-2 IgG in post COVID-19 patients. Anti-RBD SARS CoV-2 IgG antibodies in patient serum were analysed by standardised indirect ELISA using SARS CoV-2 spike receptor binding domain protein and HRP conjugated anti-human IgG antibody (anti-h IgG). The study was conducted using 35 adult patient samples with confirmed SARS CoV-2 infection. Additionally, correlation between antibody response after each stage and disease symptoms in post COVID-19 patients were studied. Maximum antibody titre was seen at Day 40 and decreased relatively to Day 180 in antibody positive samples when compared with controls. Overall, more IgG antibody expression is observed in patients who suffered from loss of smell and taste at Day 40. 71% of the positive subjects in this study showed high SARS CoV-2 IgG antibody concentration of above 10 ng/mL and 37% showed strong antibody concentration above 20 ng/mL at the peak of seroconversion. |
Databáze: | OpenAIRE |
Externí odkaz: |